Literature DB >> 3085777

Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions--2.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3085777      PMCID： PMC1340190          DOI： 10.1136/bmj.292.6529.1190

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Hypercarotenaemia in Ghanaians.

Authors:  M DAGADU; J GILLMAN
Journal:  Lancet       Date:  1963-03-09       Impact factor: 79.321

2.  New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens.

Authors:  F Labrie; A Dupont; A Belanger; Y Lacoursiere; J P Raynaud; J M Husson; J Gareau; A T Fazekas; J Sandow; G Monfette
Journal:  Prostate       Date:  1983       Impact factor: 4.104
  2 in total
  26 in total

Review 1.  Is there scope for improving the cost-effective prescribing of nonsteroidal anti-inflammatory drugs?

Authors:  K Bloor; A Maynard
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

Review 2.  Is there a rational basis for the different spectra of adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs)?

Authors:  K Brune
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  Interactions between non-steroidal anti-inflammatory drugs and H2-receptor antagonists or prostaglandin analogues.

Authors:  J S Dixon; M C Page
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 4.  Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

Authors:  Ruth Savage
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  A lack of pharmacokinetic interaction between ranitidine and piroxicam.

Authors:  J S Dixon; L F Lacey; M E Pickup; S J Langley; M C Page
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs.

Authors:  J Y Jouzeau; B Terlain; A Abid; E Nédélec; P Netter
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546

Review 7.  NSAID-induced gastrointestinal damage. Epidemiology, risk and prevention, with an evaluation of the role of misoprostol. An Asia-Pacific perspective and consensus.

Authors:  G D Champion; P H Feng; T Azuma; D E Caughey; K H Chan; S Kashiwazaki; H C Liu; A R Nasution; M Nobunaga; S Prichanond; T P Torralba; V Udom; D Utis; S R Wang; W S Wong; D J Yang; M C Yoo
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

8.  Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.

Authors:  Dorsey M Bass; Mary Prevo; Deborah S Waxman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

9.  Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.

Authors:  R A J Ransford; M J S Langman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

Review 10.  From peptic ulcer disease to NSAID gastropathy. An evolving nosology.

Authors:  S H Roth
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.